Form 4/A for OPRX OptimizeRx Corp
Accepted 2024-05-06 00:00:00 ET · period of report 2024-03-01 · accession 0001628280-24-020819 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-05-06 | 2024-03-01 | OPRX | Silvestro Stephen L | Chief Commercial Off | F - Tax | $15.95 | -572 | 18.3K | -3% | -$9,123 |
| A | 2024-05-06 | 2024-03-01 | OPRX | Silvestro Stephen L | Chief Commercial Off | M - OptEx | $0.00 | +1,927 | 18.8K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | F | D | 572 | $15.95 | 18,261 | D | — | — | (F3) These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. The original Form 4 filed by the Reporting Person reporting this transaction overstated the number of shares withheld by the Issuer. |
| 2 | Common | Common Stock | 2024-03-01 | M | A | 1,927 | $0.00 | 18,833 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock. (F2) A prior Form 4 filed by the Reporting Person failed to carry-forward previously owned shares, resulting in an understatement of the shares beneficially owned by the Reporting Person. The total amount beneficially owned has been adjusted to correct such inadvertent understatement. |